People living with Diabetes Mellitus can suffer from many neurovascular complications, which are accompanied by a high economic and social cost.
Cuban Medical Services offers comprehensive care to diabetics, including the use of the new and unique drug Heberprot-P®, prescribed for diabetic foot ulcer therapy, supported by the experience of professionals from the Institute of Angiology and Vascular Surgery and the Institute of Endocrinology.
Heberprot-P® is a lyophilized product containing recombinant human epidermal growth factor. It is developed by the Center for Genetic Engineering and Biotechnology and applied by specialized personnel specifically trained in the use of this drug. It is applied to individuals of any age, sex and race, regardless of the type of diabetes. It has been the definitive and effective answer to this health problem.
The medical program consists of an initial evaluation that includes: consultations with specialists, basic and specific complementary investigations, as well as procedures for the preparation of the areas to be treated with the medication (4 days of hospitalization); and, a second stage of drug treatment where the infiltration with Heberprot-P® is performed in the lesions (26 days of hospitalization).
Advantages with the use of Heberprot-P®:
- Stimulates granulation and healing in a progressive and sustained manner.
- Reduces the number of debridement and surgical interventions.
- Reduces the number of recurrences.
- Reduces the healing time and with it, the derived complications, such as gangrene and infection or over-infection, since the wound becomes deeper and more tissue debridement or even amputation is required.
- Reduces hospital stay costs.
- Increases the patient's quality of life and functional recovery.
- It decreases the chances of infection and allows people to incorporate more quickly to social life.
To begin treatment, you should contact the Coordination and Processing Center of Comercializadora de Servicios Médicos Cubanos, S.A. at smc@smcsalud.cu. You will be sent the medical program with its costs.
Cuban Medical Services offers comprehensive care to diabetics, including the use of the new and unique drug Heberprot-P®, prescribed for diabetic foot ulcer therapy, supported by the experience of professionals from the Institute of Angiology and Vascular Surgery and the Institute of Endocrinology.
Heberprot-P® is a lyophilized product containing recombinant human epidermal growth factor. It is developed by the Center for Genetic Engineering and Biotechnology and applied by specialized personnel specifically trained in the use of this drug. It is applied to individuals of any age, sex and race, regardless of the type of diabetes. It has been the definitive and effective answer to this health problem.
The medical program consists of an initial evaluation that includes: consultations with specialists, basic and specific complementary investigations, as well as procedures for the preparation of the areas to be treated with the medication (4 days of hospitalization); and, a second stage of drug treatment where the infiltration with Heberprot-P® is performed in the lesions (26 days of hospitalization).
Advantages with the use of Heberprot-P®:
- Stimulates granulation and healing in a progressive and sustained manner.
- Reduces the number of debridement and surgical interventions.
- Reduces the number of recurrences.
- Reduces the healing time and with it, the derived complications, such as gangrene and infection or over-infection, since the wound becomes deeper and more tissue debridement or even amputation is required.
- Reduces hospital stay costs.
- Increases the patient's quality of life and functional recovery.
- It decreases the chances of infection and allows people to incorporate more quickly to social life.
To begin treatment, you should contact the Coordination and Processing Center of Comercializadora de Servicios Médicos Cubanos, S.A. at smc@smcsalud.cu. You will be sent the medical program with its costs.